A Full-Services Model for Licensed Products
The FRILAB Group has developed a comprehensive Full-Services approach encompassing Regulatory Affairs, Distribution, and Product Promotion, providing partners with an integrated solution for market development and commercialization.
Pharmaceutical Supports
One of FRILAB’s key strengths is its ability to manage the pharmaceutical and regulatory aspects required for successful product development across multiple territories.
To achieve this, FRILAB has established a dedicated organization through its Regulatory Affairs Officer (RAO) Network, directly managed by FRILAB’s Regulatory Affairs Department and coordinated through the Hub.
In practical terms, we provide :
- Registration and renewal of your Marketing Authorizations (MAs)
- Compliance management of Marketing Authorizations following regulatory variations and updates
- Advancement of regulatory management and administrative costs
- Comprehensive pharmacovigilance management, supported by qualified QPPVs in each country
Logistics Support & Financial Security
To ensure efficient distribution across multiple territories, FRILAB relies on three pharmaceutical logistics platforms located in France, facilitating supply chain organization while providing financial reliability and payment security.
Our logistics services include:
- Centralization of deliveries from 42 manufacturing sites, as well as from our partner facilities, through our pharmaceutical distribution centers
- Collaboration with qualified logistics providers fully compliant with GDP (Good Distribution Practices) requirements, including E.P.DIS, TEDIS, and LAPHAL
Commercial & Promotional Support
FRILAB differentiates itself from traditional export promotion networks through its commitment to directly managing the training, supervision, and development of its medical promotion teams.
This approach includes :
- Deployment of dedicated promotion networks in both retail pharmacy and hospital sectors, ensuring market coverage across all relevant product segments
- An organization structured around a regional Hub in Abidjan and six subsidiaries responsible for managing promotional networks across their respective territories. In smaller markets with sufficient activity, our partners host dedicated and exclusive Medical Representatives.
- Complete control of promotional investments and expenditures, including salaries, incentive programs, equipment, Continuing Medical Education (CME) activities, scientific symposia, and promotional events
Territorial Development
Emerging markets, particularly Africa, remain at the heart of FRILAB’s growth strategy.
After more than 40 years of experience, FRILAB is now present in over 46 countries and continues to expand into new markets every year. New European partners regularly join the Group, attracted by our organizational model and our extensive knowledge of the African continent.
For our partners, joining FRILAB means:
- Benefiting from the expertise of a well-established and recognized pharmaceutical group across numerous territories
- Building a long-term development strategy with the opportunity to expand across Francophone, Anglophone, Arabophone, and Lusophone markets
- Participating in the growth of a company whose longstanding ambition is to achieve comprehensive coverage of the African pharmaceutical market
By combining regulatory expertise, supply chain excellence, financial reliability, and strong field promotion capabilities, FRILAB provides its partners with a unique platform for sustainable growth across emerging markets.